Oncology & Cancer

Rolapitant reduces nausea and vomiting in Phase III trial

Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial presented for the first time today at the ESMO 2014 Congress in Madrid, Spain.

Addiction

Alcohol abuse, eating disorders share genetic link

Part of the risk for alcohol dependence is genetic, and the same is true for eating disorders. Now, researchers at Washington University School of Medicine in St. Louis have found it's likely some of the same genes are involved ...

Psychology & Psychiatry

Study finds link between sexual harassment and 'purging'—in men

Men who experience high levels of sexual harassment are much more likely than women to induce vomiting and take laxatives and diuretics in an attempt to control their weight, according to a surprising finding by Michigan ...

Medications

Researchers begin trial of Shigella vaccine candidates

Researchers have launched an early-stage human clinical trial of two related candidate vaccines to prevent infection with Shigella, bacteria that are a significant cause of diarrheal illness, particularly among children. ...

page 4 from 10